Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation (original) (raw)

Correlation between Viral Loads of Cytomegalovirus in Blood and Bronchoalveolar Lavage Specimens from Lung Transplant Recipients Determined by Histology and Immunohistochemistry

Steven Gordon

Journal of Clinical Microbiology, 2004

View PDFchevron_right

The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation

Ron Walker

Bone Marrow Transplantation, 1998

View PDFchevron_right

Clinical Utility of Cytomegalovirus Viral Load in Bronchoalveolar Lavage in Lung Transplant Recipients: Clinical Utility of Cytomegalovirus Viral Load

nabin shrestha

American Journal of Transplantation, 2005

View PDFchevron_right

Circulating Cytomegalovirus (CMV)‐Infected Endothelial Cells in Marrow Transplant Patients with CMV Disease and CMV Infection

Bernd Salzberger

The Journal of Infectious Diseases, 1997

View PDFchevron_right

Clinical Utility of Cytomegalovirus Viral Load in Bronchoalveolar Lavage in Lung Transplant Recipients

Steven Gordon

American Journal of Transplantation, 2005

View PDFchevron_right

Differences in CMV-Specific T-Cell Levels and Long-Term Susceptibility to CMV Infection after Kidney, Heart and Lung Transplantation

Urban Sester, A. Meyerhans

American Journal of Transplantation, 2005

View PDFchevron_right

Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?

A. Fajac

British Journal of Haematology, 1997

View PDFchevron_right

Human Cytomegalovirus Load in Plasma and Bronchoalveolar Lavage Fluid: A Longitudinal Study of Lung Transplant Recipients

Trevor Williams

The Journal of Infectious Diseases, 2004

View PDFchevron_right

Cytomegalovirus infections after transfusion and transplantations: some studies of pathogenesis

ravi pottathil

View PDFchevron_right

CD4 + T cell levels are decreased during active CMV infection in kidney transplant recipients

Raja'a Al-Attiyah

FEMS Immunology & Medical Microbiology, 2002

View PDFchevron_right

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients

Paolo Solidoro

Transplantation, 2016

View PDFchevron_right

Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation

Jan Reuel Ganoria

Bone Marrow Transplantation, 1997

View PDFchevron_right

Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients

Diana Westmoreland

Clinical Microbiology and Infection, 2001

View PDFchevron_right

Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation

Pilar Blanco Lobo

The Journal of infection, 2016

View PDFchevron_right

Persistent Cytomegalovirus-Specific Memory Responses in the Lung Allograft and Blood following Primary Infection in Lung Transplant Recipients

Marvin Borja

The Journal of Immunology, 2006

View PDFchevron_right

Effect of CMV-immunoglobulins (cytotect biotest) prophylaxis on CMV pneumonia after lung transplantation

Massimiliano Bergallo, Paolo Solidoro

The new microbiologica, 2011

View PDFchevron_right

The occurrence of symptomatic CMV infections in heart transplant recipients

Eva Goncalvesova

Bratislavske lekarske listy

View PDFchevron_right

Value of cytomegalovirus detection by PCR in bronchoalveolar lavage routinely performed in asymptomatic bone marrow recipients

A. Fajac

Bone Marrow Transplantation, 1997

View PDFchevron_right

Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice

Paolo Solidoro

Therapeutic Advances in Respiratory Disease, 2020

View PDFchevron_right

Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients

abdul abdul rahman nur

Thorax, 1995

View PDFchevron_right

Difference in the Cytomegalovirus-related Clinical Laboratory Findings Between Patients With Bone Marrow and Kidney Transplantations

Research in Molecular Medicine (RMM)

Research in Molecular Medicine, 2021

View PDFchevron_right

Changes in cell-mediated immunity in kidney transplant recipients with active CMV infection

Raj Raghupathy

FEMS Immunology & Medical Microbiology, 2002

View PDFchevron_right

Cytomegalovirus Pneumonia Ten Years After Renal Transplant–A Manifestation Of Sustained Lymphocyte Depletion

Leonídio Dias

View PDFchevron_right

Clinical Manifestation, Laboratory Findings, and the Response of Treatment in Kidney Transplant Recipients With CMV Infection

Patricia Khashayar

Transplantation Proceedings, 2007

View PDFchevron_right

Quantification of cytomegalovirus (CMV) viral load by the hybrid capture assay allows for early detection of CMV disease in lung transplant recipients

V. Yeldandi

The Journal of Heart and Lung Transplantation, 2001

View PDFchevron_right